GLENMARK LIFE SCIENCES
Back to Cashflow Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-279 Cr | ₹-388 Cr | ₹-79 Cr | ₹-214 Cr | ₹-137 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLENMARK LIFE SCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-279 Cr |
Mar2023 | ₹-388 Cr |
Mar2022 | ₹-79 Cr |
Mar2021 | ₹-214 Cr |
Mar2020 | ₹-137 Cr |
How is Cash Flow from Financing Activities of GLENMARK LIFE SCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-279 Cr | Negative | |
Mar2023 | ₹-388 Cr | Negative | |
Mar2022 | ₹-79 Cr | Negative | |
Mar2021 | ₹-214 Cr | Negative | |
Mar2020 | ₹-137 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,392.3 Cr | 1% | 1.9% | 67.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,996.0 Cr | 3.3% | -1.8% | 51.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,016.0 Cr | 6.6% | 7.3% | 63.4% | Stock Analytics | |
CIPLA | ₹121,416.0 Cr | 2.6% | 1.3% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,877.0 Cr | 1.3% | -8.5% | 8.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,096.5 Cr | 2.1% | -3.6% | 49.2% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | 1% |
1.9% |
67.7% |
SENSEX | 3.3% |
-0.1% |
21.8% |
You may also like the below Video Courses